Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Allergic Reactions

Allergic Reactions

Allergic Reactions: Anaphylaxis

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Cross-reactivity

Cross-reactivity

Antibody Structure

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Shwachman-Diamond syndrome presenting with early ichthyosis, associated dermal and epidermal intracellular lipid droplets, hypoglycemia, and later distinctive clinical SDS phenotype.

American journal of medical genetics. Part A·2016

Same author

Basis for enhanced barrier function of pigmented skin.

The Journal of investigative dermatology·2014

Same author

Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.

The Journal of investigative dermatology·2012

Same author

Caspase-14-deficient mice are more prone to the development of parakeratosis.

The Journal of investigative dermatology·2012

Same author

Cannabinoid receptors 1 and 2 oppositely regulate epidermal permeability barrier status and differentiation.

Experimental dermatology·2012

Same author

Cellular changes that accompany shedding of human corneocytes.

The Journal of investigative dermatology·2012

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Proteolytically active allergens cause barrier breakdown.

Truus Roelandt¹, Carol Heughebaert, Jean-Pierre Hachem

¹Dienst Dermatologie, Universitair Ziekenhuis-Vrije Universiteit Brussel, Brussels, Belgium.

The Journal of Investigative Dermatology

|July 16, 2008

Summary

House dust mite and cockroach allergens activate protease-activated receptor 2 (PAR-2), delaying skin barrier recovery. This study explores the link between barrier function and immune responses.

More Related Videos

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

Related Experiment Videos

Last Updated: Jul 3, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Removal and Replacement of Endogenous Ligands from Lipid-Bound Proteins and Allergens

Published on: February 24, 2021

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

Area of Science:

Immunology
Dermatology
Allergology

Background:

Major allergens like Dermatophagoides pteronyssinus (Der p 1) and cockroach allergens possess proteolytic activity.
These allergens are known to activate the protease-activated receptor 2 (PAR-2) signaling pathway.

Discussion:

Jeong et al. demonstrated that exposure of mouse and human epidermis to these allergens delays permeability barrier recovery.
The delay in barrier recovery was correlated with PAR-2 activation and subsequent signaling.

Key Insights:

Proteolytic allergens directly impact skin barrier function by activating PAR-2.
PAR-2 signaling plays a crucial role in regulating skin barrier homeostasis.
This research highlights the intricate relationship between epidermal barrier integrity and immune system activation.

Outlook:

Further investigation into PAR-2 modulation could offer novel therapeutic strategies for allergic skin diseases.
Understanding the interplay between barrier homeostasis and immunity is vital for developing targeted treatments.
This study opens avenues for exploring how environmental allergens influence skin health and immune responses.